Clinical data, such as GH and IGF-I levels, do not always correlate to patient-perceived health [26], and the development of ACRODAT®27 (Acromegaly Disease Activity Tool), a specific tool for measuring acromegaly disease activity, improved understanding of the condition by including QoL among the parameters evaluated. This evidence concerns the gene GH1 and acromegaly.